| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6062092 | Annals of Allergy, Asthma & Immunology | 2014 | 8 Pages |
Abstract
Relief of symptoms of HAE attacks was achieved faster with rhC1INH compared with placebo as assessed by the TEQ and VAS, with a positive safety profile. Results are consistent with previous studies showing efficacy and safety of rhC1INH in patients with HAE.
Related Topics
Health Sciences
Medicine and Dentistry
Dermatology
Authors
Marc A. MD, Jonathan A. MD, Henry MD, Avner MD, William MD, Dumitru MD, Henriette MD, Robyn MD, James MD, Yun MS, Mark C. MD, Anurag MD, Marco MD, Study 1310 Investigators Study 1310 Investigators,